NASDAQ:HHS - US4161962026 - Common Stock
The current stock price of HHS is 3.72 USD. In the past month the price increased by 3.81%. In the past year, price decreased by -51.61%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TTD | TRADE DESK INC/THE -CLASS A | 30.3 | 25.77B | ||
OMC | OMNICOM GROUP | 9.55 | 15.16B | ||
IPG | INTERPUBLIC GROUP OF COS INC | 9.29 | 9.82B | ||
WPP | WPP PLC-SPONSORED ADR | 5 | 5.71B | ||
NIQ | NIQ GLOBAL INTELLIGENCE PLC | N/A | 4.88B | ||
MGNI | MAGNITE INC | 30.94 | 3.66B | ||
MNTN | MNTN INC-A | N/A | 1.50B | ||
IAS | INTEGRAL AD SCIENCE HOLDING | 26.44 | 1.49B | ||
STGW | STAGWELL INC | 7.37 | 1.43B | ||
CRTO | CRITEO SA-SPON ADR | 5.22 | 1.29B | ||
EEX | EMERALD HOLDING INC | 64.25 | 1.02B | ||
IBTA | IBOTTA INC-CL A | 19.26 | 721.86M |
Harte-Hanks, Inc. is a global customer experience company operating in three business segments: Marketing Services, Customer Care, and Fulfillment & Logistics Services. The company is headquartered in Chelmsford, Massachusetts and currently employs 1,715 full-time employees. The firm operates through four segments: Marketing Services; Customer Care, Sales Service, and Fulfillment & Logistics Services. Marketing Services segment leverages data, insight, and experience to support clients as they engage customers through digital, traditional, and emerging channels. Customer Care segment offers responsive contact center solutions, which use real-time data to interact with each customer. Customer contacts are handled through phone, e-mail, social media, text messaging, chat, and digital self-service support. Fulfillment & Logistics segment comprises mail, product fulfillment, and logistics services. The company offers a variety of product fulfillment solutions, including printing on demand, managing product recalls, and distributing literature and promotional products. The company is also a third-party logistics and freight optimization provider in the United States.
HARTE-HANKS INC
1 Executive Drive, Suite 303
Chelmsford MASSACHUSETTS 78728 US
CEO: Andrew Benett
Employees: 1859
Phone: 15124341100
The current stock price of HHS is 3.72 USD. The price increased by 2.2% in the last trading session.
The exchange symbol of HARTE-HANKS INC is HHS and it is listed on the Nasdaq exchange.
HHS stock is listed on the Nasdaq exchange.
HARTE-HANKS INC (HHS) has a market capitalization of 27.57M USD. This makes HHS a Nano Cap stock.
HARTE-HANKS INC (HHS) currently has 1859 employees.
HARTE-HANKS INC (HHS) has a support level at 3.28 and a resistance level at 3.66. Check the full technical report for a detailed analysis of HHS support and resistance levels.
The Revenue of HARTE-HANKS INC (HHS) is expected to grow by 4.05% in the next year. Check the estimates tab for more information on the HHS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HHS does not pay a dividend.
HARTE-HANKS INC (HHS) will report earnings on 2025-11-12.
HARTE-HANKS INC (HHS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.41).
The outstanding short interest for HARTE-HANKS INC (HHS) is 0.43% of its float. Check the ownership tab for more information on the HHS short interest.
ChartMill assigns a technical rating of 2 / 10 to HHS. When comparing the yearly performance of all stocks, HHS is a bad performer in the overall market: 94.67% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to HHS. While HHS seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months HHS reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 89.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -3.18% | ||
ROE | -13.57% | ||
Debt/Equity | 0.02 |
For the next year, analysts expect an EPS growth of 131.2% and a revenue growth 4.05% for HHS